Skip to content
10-K

Annual Report

KRAIG BIOCRAFT LABORATORIES, INC. KBLB

0001641172-25-001238

← back to feed
Filed
Mar 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 28, 2025 1.04B sh
Shares Diluted FY 2024 · Dec 31, 2023 1.03B sh
Capex FY 2024 · Dec 31, 2023 $6.4K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$1.24M
Cash And Equivalents FY 2024 · Dec 31, 2023 $2.55M
Current Liabilities FY 2024 · Dec 31, 2023 $8.89M
Total Liabilities FY 2024 · Dec 31, 2023 $8.94M
Current Assets FY 2024 · Dec 31, 2023 $2.57M
Total Assets FY 2024 · Dec 31, 2023 $3.23M
Eps Diluted FY 2024 · Dec 31, 2023 $0.00
Eps Basic FY 2024 · Dec 31, 2023 $0.00
Sga Expense FY 2024 · Dec 31, 2023 $1.45M
Rd Expense FY 2024 · Dec 31, 2023 $237.87K
Net Income FY 2024 · Dec 31, 2023 −$3.03M
Operating Income FY 2024 · Dec 31, 2023 −$2.61M
Stockholders Equity FY 2024 · Dec 31, 2022 −$3.52M